Curriculum Vitae

1- Rawa Ratha, Tagreed Altaei. Therapeutic Drug Monitoring of Chelating Agent Deferoxamine for β-Thalassemia Major Patients. International Journal of Clinical Medicine, 2013, 4, 331-342. Impact Factor (0.2) according to Clarivate Analytics (Thomson Reuters).

2- Rawa Ratha, Dler M.salh, and Dlzar D. Ghafoor. Effect of Desferrioxamine Injection on Some Metal Ions in β-Thalassemia Major Patients. International Journal of Basic & Applied Sciences 2015; 15 (5): 25-27. Impact factor (0.39) according to Clarivate Analytics (Thomson Reuters).

3- Esmail V, Hamid D, Ratha R. Prevalence of flu-like syndrome among chronic hepatitis C infected patients treated with the first line combination therapy (pegylated interferon A-2a and ribavirin). International Journal of Development Research, 2016; 6(2): 6605-6608.

4- Esmail V, Hamid D, Ratha R. Pegylated interferon a-2a therapy and occurrence of sinus tachycardia in chronic hepatitis C infected patients. Donnish Journal of Medicine and Medical Sciences, 2016; 3(1): 001-005.

5- Marwan Al-Nimer, Rawa Ratha, Taha Mahwi. Pentoxifylline improves the quality of life in type-2 diabetes foot syndrome. Pakistan Journal of Medical sciences 2019; 35 (5): 1370-1375. Impact factor (0.834) according to Clarivate Analytics (Thomson Reuters).

6- Marwan Al-Nimer, Rawa Ratha, and Taha Mahwi, “Utility of Tetrahydrobiopterin Pathway in the Assessment of Diabetic Foot Ulcer: Significant and Complex Interrelations,” Journal of Diabetes Research, vol. 2019, Article ID 3426878, 7 pages, 2019. https://doi.org/10.1155/2019/3426878. Impact factor (3.04) according to Clarivate Analytics (Thomson Reuters).